Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Khusru Asadullah

Showing results (41-50 of 68) with videos related to

Pageof 7
Sort By:
The Journal of Investigative Dermatology|March 29, 2002
Immunomodulation by interleukin-10 therapy decreases the incidence of relapse and prolongs the relapse-free interval in PsoriasisMarkus Friedrich, Wolf-Dietrich Döcke, Anja Klein, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|May 25, 2020
Cytokines of the IL-17 family in psoriasisFelix Lauffer, Kilian Eyerich, Wolf-Henning Boehncke, et al.
Cellular Immunology|April 11, 2009
Induction of Foxp3+ regulatory T cells with histone deacetylase inhibitorsJulie L Lucas, Parham Mirshahpanah, Eric Haas-Stapleton, et al.
Journal of Leukocyte Biology|April 24, 2009
IL-10 protects monocytes and macrophages from complement-mediated lysisNadine Koch, Mechthild Jung, Robert Sabat, et al.
Experimental Dermatology|April 17, 2004
Biology of tumor necrosis factor-alpha- implications for psoriasisArndt J G Schottelius, Lyle L Moldawer, Charles A Dinarello, et al.
Experimental Dermatology|April 19, 2003
Keratinocyte unresponsiveness towards interleukin-10: lack of specific binding due to deficient IL-10 receptor 1 expressionMartina Seifert, Beate H Gruenberg, Robert Sabat, et al.
Journal of Leukocyte Biology|November 29, 2008
Comprehensive biomarker monitoring in cytokine therapy: heterogeneous, time-dependent, and persisting immune effects of interleukin-10 application in psoriasisWolf-Dietrich Döcke, Khusru Asadullah, Gudrun Belbe, et al.
The Journal of Investigative Dermatology|November 25, 2003
Ultraviolet B radiation-mediated inhibition of interferon-gamma-induced keratinocyte activation is independent of interleukin-10 and other soluble mediators but associated with enhanced intracellular suppressors of cytokine-signaling expressionMarkus Friedrich, Ruth Holzmann, Wolfram Sterry, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 25, 2003
Dissociation of transactivation from transrepression by a selective glucocorticoid receptor agonist leads to separation of therapeutic effects from side effectsHeike Schäcke, Arndt Schottelius, Wolf-Dietrich Döcke, et al.
Experimental Dermatology|September 12, 2007
Immunopathogenesis of psoriasisRobert Sabat, Sandra Philipp, Conny Höflich, et al.
Pageof 7

Showing results (41-50 of 68) with videos related to

Sort By:
Pageof 7
The Journal of Investigative Dermatology|March 29, 2002
Immunomodulation by interleukin-10 therapy decreases the incidence of relapse and prolongs the relapse-free interval in PsoriasisMarkus Friedrich, Wolf-Dietrich Döcke, Anja Klein, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|May 25, 2020
Cytokines of the IL-17 family in psoriasisFelix Lauffer, Kilian Eyerich, Wolf-Henning Boehncke, et al.
Cellular Immunology|April 11, 2009
Induction of Foxp3+ regulatory T cells with histone deacetylase inhibitorsJulie L Lucas, Parham Mirshahpanah, Eric Haas-Stapleton, et al.
Journal of Leukocyte Biology|April 24, 2009
IL-10 protects monocytes and macrophages from complement-mediated lysisNadine Koch, Mechthild Jung, Robert Sabat, et al.
Experimental Dermatology|April 17, 2004
Biology of tumor necrosis factor-alpha- implications for psoriasisArndt J G Schottelius, Lyle L Moldawer, Charles A Dinarello, et al.
Experimental Dermatology|April 19, 2003
Keratinocyte unresponsiveness towards interleukin-10: lack of specific binding due to deficient IL-10 receptor 1 expressionMartina Seifert, Beate H Gruenberg, Robert Sabat, et al.
Journal of Leukocyte Biology|November 29, 2008
Comprehensive biomarker monitoring in cytokine therapy: heterogeneous, time-dependent, and persisting immune effects of interleukin-10 application in psoriasisWolf-Dietrich Döcke, Khusru Asadullah, Gudrun Belbe, et al.
The Journal of Investigative Dermatology|November 25, 2003
Ultraviolet B radiation-mediated inhibition of interferon-gamma-induced keratinocyte activation is independent of interleukin-10 and other soluble mediators but associated with enhanced intracellular suppressors of cytokine-signaling expressionMarkus Friedrich, Ruth Holzmann, Wolfram Sterry, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 25, 2003
Dissociation of transactivation from transrepression by a selective glucocorticoid receptor agonist leads to separation of therapeutic effects from side effectsHeike Schäcke, Arndt Schottelius, Wolf-Dietrich Döcke, et al.
Experimental Dermatology|September 12, 2007
Immunopathogenesis of psoriasisRobert Sabat, Sandra Philipp, Conny Höflich, et al.
Pageof 7